IL-6 trans-signaling has been implicated in the pathogenesis of numerous inflammatory conditions and malignancies, the latter including those to which ADAM17 has also been associated with, namely CRC, pancreatic cancer and lung cancer [29,97,213,214,215,216,217]. Here, ADAM17 is linked to familial pancreatic carcinoma.